Filed Pursuant to Rule 424(b)(5)
Registration No. 333-236577
PROSPECTUS SUPPLEMENT
(To prospectus dated February 21, 2020)
$215,000,000
1.75% Convertible Senior Notes Due 2026
Pebblebrook Hotel Trust is offering $215,000,000 aggregate principal amount of its 1.75% Convertible Senior Notes due 2026, or the additional notes, under this prospectus supplement. Interest on the additional notes will be payable semiannually in arrears on June 15 and December 15 of each year, beginning on June 15, 2021. The notes will mature on December 15, 2026.
The additional notes offered hereby will be fully fungible with, and will rank equally in right of payment with and form a single series with, the $500,000,000 aggregate principal amount of the 1.75% Convertible Senior Notes due 2026 we issued on December 15, 2020, or the initial notes. We refer to the initial notes and the additional notes, collectively, as the “notes.” Upon completion of this offering, we will have $715,000,000 aggregate principal amount of the notes outstanding (or up to $750,000,000 aggregate principal amount of the notes outstanding if the underwriters' exercise their over-allotment option in full). The additional notes offered hereby will be issued under our existing base indenture dated as of December 15, 2020, as supplemented by our existing first supplemental indenture, dated as of December 15, 2020, between Pebblebrook Hotel Trust and The Bank of New York Mellon Trust Company, N.A., as trustee, and will have terms identical to the terms of the initial notes, will have the same CUSIP number as the initial notes and are expected to trade interchangeably with the initial notes.
Holders may convert the notes at their option prior to the close of business on the business day immediately preceding June 15, 2026, but only under the following circumstances: (1) during any fiscal quarter commencing after March 31, 2021 (and only during such fiscal quarter), if the last reported sale price of our common shares of beneficial interest, $0.01 par value per share, or our common shares, for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price for the notes on each applicable trading day; (2) during the five consecutive business day period after any five consecutive trading day period, or the measurement period, in which the trading price (as defined herein) per $1,000 principal amount of notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of our common shares and the conversion rate for the notes on each such trading day; (3) if we call any or all of the notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or (4) upon the occurrence of specified corporate events. On or after June 15, 2026, until the close of business on the second scheduled trading day immediately preceding the maturity date of the notes, holders may convert their notes at any time, regardless of the foregoing circumstances. Upon conversion of a note, we will pay or deliver, as the case may be, cash, common shares or a combination of cash and our common shares, at our election, as described in this prospectus supplement.
The conversion rate applicable to the notes will initially equal 39.2549 of our common shares per $1,000 principal amount of notes (equivalent to a conversion price of approximately $25.47 per common share). The conversion rate will be subject to adjustment upon the occurrence of certain events, but will not be adjusted for any accrued and unpaid interest. In addition, following the occurrence of a make-whole fundamental change or if we provide notice of redemption, we will, in certain circumstances, increase the conversion rate for a holder that converts its notes in connection with such make-whole fundamental change or notice of redemption, as the case may be.
We may redeem for cash all or any portion of the notes, at our option, on or after December 20, 2023 if the last reported sale price of our common shares has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption. The redemption price will be equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. No sinking fund is provided for the notes.
If we undergo a fundamental change, holders may require us to purchase the notes in whole or in part for cash at a fundamental change purchase price equal to 100% of the principal amount of the notes to be purchased, plus accrued and unpaid interest, if any, to, but excluding, the fundamental change purchase date.
The notes will be our senior unsecured obligations and will rank senior in right of payment to any future indebtedness that is expressly subordinated in right of payment to the notes, equal in right of payment to our existing and future unsecured indebtedness that is not so subordinated, effectively junior to any future secured indebtedness to the extent of the value of the assets securing such indebtedness and structurally junior to all existing and future indebtedness (including trade payables) and preferred equity of our subsidiaries, other than to the extent the notes are guaranteed in the future by our subsidiaries, as described in this prospectus supplement.
We do not intend to apply for listing of the notes on any securities exchange. Our common shares are listed on the New York Stock Exchange, or the NYSE, under the trading symbol “PEB.” The last reported sale price of our common shares on the NYSE on February 4, 2021 was $20.10 per share.
Investing in the notes involves certain risks. See “Risk Factors” in this prospectus supplement and the reports we file with the Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934, that are incorporated by reference into this prospectus supplement and the accompanying prospectus to read about factors you should consider before making an investment in the notes.
| | | Per Note | | | Total | |
Public offering price(1) | | | | | 105.5% | | | | | $ | 226,825,000 | | |
Underwriting discount and commissions | | | | | 2.5% | | | | | $ | 5,375,000 | | |
Proceeds, before expenses, to us(1) | | | | | 103.0% | | | | | $ | 221,450,000 | | |
(1)
The public offering price and the proceeds, before expenses, to us, will include accrued interest from, and including, December 15, 2020, to, but excluding, February 9, 2021, in the amount of $2.58 per note. The table above does not reflect such accrued interest.
The underwriters will have the option to purchase within 13 days beginning on and including the date on which we first issue the notes up to an additional $35,000,000 principal amount of notes, or the option notes, from us at the public offering price less the underwriting discount solely to cover over-allotments, if any.
The underwriters expect to deliver the notes in book-entry form only through the facilities of The Depository Trust Company on or about February 9, 2021.
Joint Book-Running Managers
BofA SecuritiesRaymond JamesWells Fargo Securities Truist Securities
Co-Lead Managers
| US Bancorp | | | PNC Capital Markets LLC | |
Co-Managers
| Capital One Securities | | | Regions Securities LLC | | | BMO Capital Markets | |
| Scotiabank | | | SMBC Nikko | | | TD Securities | |
The date of this prospectus supplement is February 4, 2021.